Correlation between the expression of IL‑18 and deep venous thrombosis Corrigendum in /10.3892/ijmm.2018.3843

Li,Guangdi; Zhou,Rudan; Zhao,Xueling; Liu,Riguang; Ye,Chuan

doi:10.3892/ijmm.2018.3682

Correlation between the expression of IL‑18 and deep venous thrombosis

Corrigendum in: /10.3892/ijmm.2018.3843

Authors:
- Guangdi Li
- Rudan Zhou
- Xueling Zhao
- Riguang Liu
- Chuan Ye
View Affiliations

Affiliations: Department of Orthopedics, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China, Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China
Published online on: May 16, 2018 https://doi.org/10.3892/ijmm.2018.3682
Pages: 883-896
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of the expression of interleukin (IL)‑18 and related markers on deep venous thrombosis (DVT) to examine their correlation. Sprague‑Dawley rats of different models were established and were randomly assigned into three groups. The expression of IL‑18, nuclear factor (NF)‑κB and von Willebrand factor (vWF) were detected in blood samples. The inferior vena cava (IVC) was ligated to establish the DVT model. Rat IL‑18 overexpression and inhibition vectors were constructed. The expression levels of IL‑18 and related markers in the venous wall were compared between the model group and the control group using reverse transcription‑quantitative polymerase chain reaction and western blot analyses. Following the culture of human umbilical vein endothelial cells (HUVECs), IL‑18 was added to the cells, following which the growth of the HUVECs, and changes in vWF and other endothelial functional markers were analyzed. The IVC model demonstrated complete thrombosis at 8 h and stable thrombosis at 24 h. At 24 h following model establishment, the expression levels of IL‑18, NF‑κB and vWF were high in the blood samples with the occurrence and development of thrombosis (P<0.05). The weight, length and weight/length ratio of thrombi in each model group showed significant differences from those in the control group (P<0.05) with the overexpression of IL‑18, and the expression levels of NF‑κB and vWF in venous tissues were altered with abnormal expression levels of IL‑18. IL‑18 damaged HUVECs and significantly increased viability in early‑stage apoptosis, promoted the upregulation of vWF and P‑selectin, and reduced tissue plasminogen activator. IL‑18 and the related markers were closely associated with the occurrence and development of DVT.

View Figures

View References

1	Downing LJ, Strieter RM, Kadell AM, Wilke CA, Austin JC, Hare BD, Burdick MD, Greenfield LJ and Wakefield TW: IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol. 161:1471–1476. 1998.
2	Strukova S: Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Front Biosci. 11:59–80. 2006. View Article : Google Scholar
3	Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-Schaub LB, Jensen LE and Mummidi S: Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. J Biol Chem. 279:20221–20233. 2004. View Article : Google Scholar
4	Li YD, Ye BQ, Zheng SX, Wang JT, Wang JG, Chen M, Liu JG, Pei XH, Wang LJ, Lin ZX, et al: NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem. 284:4473–4483. 2009. View Article : Google Scholar
5	Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Köllnberger M, Wakefield TW, Lämmle B, Massberg S and Wagner DD: Von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 117:1400–1407. 2011. View Article : Google Scholar
6	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
7	Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A and Wakefield TW: P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 38:1075–1089. 2003. View Article : Google Scholar
8	Henke PK, Varga A, De S, Deatrick CB, Eliason J, Arenberg DA, Sukheepod P, Thanaporn P, Kunkel SL, Upchurch GR Jr and Wakefield TW: Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol. 24:1130–1137. 2004. View Article : Google Scholar
9	Morel JC, Park CC, Woods JM and Koch AE: A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem. 276:37069–37075. 2001. View Article : Google Scholar
10	Baker RG, Hayden MS and Ghosh S: NF-kappaB, inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011. View Article : Google Scholar
11	Oeckinghaus A, Hayden MS and Ghosh S: Crosstalk in NF-κB signaling pathways. Nat Immunol. 12:695–708. 2011. View Article : Google Scholar
12	Sen R: The origins of NF-κB. Nat Immunol. 12:686–688. 2011. View Article : Google Scholar
13	Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H and Hayashi H: A novel structural class of potent inhibitors of NF-kappa B activation: Structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. Bioorg Med Chem. 11:3869–3878. 2003. View Article : Google Scholar
14	Armstrong SJ, Wiberg M, Terenghi G and Kingham PJ: Laminin activates NF-kappaB in Schwann cells to enhance neurite outgrowth. Neurosci Lett. 439:42–46. 2008. View Article : Google Scholar
15	Yang RH, Strong JA and Zhang JM: NF-kappaB mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons. Mol Pain. 5:262009. View Article : Google Scholar
16	Blann AD and Lip GY: Virchow's triad revisited: The importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res. 101:321–327. 2001. View Article : Google Scholar
17	Pan J, Zhang SQ and Chen B: Interferon-γ induces the apoptosis of vascular endothelial cell in vitro. J Bengbu Med Coll. 30:388–389. 2005.
18	Choy JC, Granville DJ, Hunt DW and McManus BM: Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol. 33:1673–1690. 2001. View Article : Google Scholar
19	Blann AD: Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years. Thromb Haemost. 95:49–55. 2006.
20	Jansson JH, Nilsson TK and Johnson O: Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J. 66:351–355. 1991. View Article : Google Scholar
21	Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G and Tavazzi L: The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb. 12:1063–1070. 1992. View Article : Google Scholar
22	Cambien B and Wagner DD: A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med. 10:179–186. 2004. View Article : Google Scholar
23	Furie B and Furie BC: Role of platelet P-selectin and micropar-ticle PSGL-1 in thrombus formation. Trends Mol Med. 10:171–178. 2004. View Article : Google Scholar
24	Rosenbaum T, Rammos S, Kniemeyer HW and Gobel U: Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: Successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms. Eur J Pediatr. 152:978–980. 1993. View Article : Google Scholar
25	Kruithof EK and Dunoyer-Geindre S: Human tissue-type plas-minogen activator. Thromb Haemost. 112:243–254. 2014. View Article : Google Scholar